A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors

Authors

Keywords

Journal

Volume 22, Issue 9, Pages 2137-2143

Publisher

Oxford University Press (OUP)

Online

2011-02-17

DOI

10.1093/annonc/mdq734

References

View 4 related references

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now